BioNexus Gene Lab (BGLC) Gross Margin (2018 - 2026)
BioNexus Gene Lab recorded quarterly Gross Margin of 3.46% in Q1 2026, down 320.06% quarter-over-quarter from 0.82% in Q4 2025, and down 1953.0% year-over-year from 0.19% in Q1 2025.
BioNexus Gene Lab's Gross Margin history runs 9 years deep, the most recent figure standing at 3.46% for Q1 2026.
- In Q1 2026, Gross Margin fell 1953.0% year-over-year to 3.46%; the TTM figure through Mar 2026 stood at 13.95% (up 27.0% YoY), while the FY2025 annual figure was 14.62%, up 106.0% from the prior year.
- Gross Margin came in at 3.46% for Q1 2026 at BioNexus Gene Lab, down from 0.82% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 16.28% in Q2 2025 to a low of 3.46% in Q1 2026.
- A 5-year average of 11.64% and a median of 12.41% in 2024 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin soared 375 bps in 2023 and tumbled 1953 bps in 2026, its largest moves.
- BioNexus Gene Lab's Gross Margin stood at 11.95% in 2022, then slipped by 2 bps to 11.73% in 2023, then rose by 4 bps to 12.25% in 2024, then sank by 107 bps to 0.82% in 2025, then sank by 320 bps to 3.46% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 3.46%, 0.82%, and 14.85% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn | 48.49% |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn | 44.24% |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn | 49.07% |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn | 44.03% |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn | 31.13% |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn | 42.11% |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn | 9.74% |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn | 35.06% |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn | 35.81% |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 | -3.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.46% |
| Dec 31, 2025 | -0.82% |
| Sep 30, 2025 | 14.85% |
| Jun 30, 2025 | 16.28% |
| Mar 31, 2025 | 16.07% |
| Dec 31, 2024 | 12.25% |
| Sep 30, 2024 | 12.41% |
| Jun 30, 2024 | 14.62% |
| Mar 31, 2024 | 15.33% |
| Dec 31, 2023 | 11.73% |
| Sep 30, 2023 | 13.88% |
| Jun 30, 2023 | 13.23% |
| Mar 31, 2023 | 15.52% |
| Dec 31, 2022 | 11.95% |
| Sep 30, 2022 | 11.63% |
| Jun 30, 2022 | 10.62% |
| Mar 31, 2022 | 11.76% |
| Dec 31, 2021 | 14.70% |
| Sep 30, 2021 | 19.83% |
| Jun 30, 2021 | 15.12% |
| Mar 31, 2021 | 16.89% |
| Dec 31, 2020 | 9.28% |
| Sep 30, 2020 | 16.89% |
| Jun 30, 2020 | 14.43% |
| Mar 31, 2020 | 21.35% |
| Dec 31, 2019 | 64.70% |
| Sep 30, 2019 | 31.75% |
| Jun 30, 2019 | 21.37% |
| Mar 31, 2019 | 32.99% |
| Dec 31, 2018 | -71.49% |
| Sep 30, 2018 | 24.41% |